Colgate-Palmolive (NYSE:CL) Price Target Raised to $107.00 at Deutsche Bank Aktiengesellschaft

Colgate-Palmolive (NYSE:CLFree Report) had its price objective raised by Deutsche Bank Aktiengesellschaft from $104.00 to $107.00 in a research report sent to investors on Monday morning, Benzinga reports. They currently have a buy rating on the stock.

A number of other analysts also recently commented on the stock. Jefferies Financial Group downgraded shares of Colgate-Palmolive from a buy rating to a hold rating and decreased their price objective for the stock from $103.00 to $95.00 in a report on Wednesday, July 24th. Wells Fargo & Company lifted their target price on shares of Colgate-Palmolive from $92.00 to $97.00 and gave the stock an equal weight rating in a research report on Wednesday, July 10th. Morgan Stanley lifted their target price on shares of Colgate-Palmolive from $101.00 to $103.00 and gave the stock an overweight rating in a research report on Tuesday, May 28th. Bank of America lifted their target price on shares of Colgate-Palmolive from $100.00 to $110.00 and gave the stock a buy rating in a research report on Wednesday, July 10th. Finally, Citigroup lifted their target price on shares of Colgate-Palmolive from $103.00 to $112.00 and gave the stock a buy rating in a research report on Wednesday, July 10th. Seven research analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of Moderate Buy and a consensus target price of $101.11.

View Our Latest Stock Report on Colgate-Palmolive

Colgate-Palmolive Stock Up 1.8 %

CL stock opened at $100.93 on Monday. The company has a market cap of $82.47 billion, a P/E ratio of 31.94, a P/E/G ratio of 3.52 and a beta of 0.39. Colgate-Palmolive has a 52 week low of $67.62 and a 52 week high of $101.42. The company’s 50-day moving average price is $96.30 and its 200 day moving average price is $90.61. The company has a current ratio of 1.06, a quick ratio of 0.28 and a debt-to-equity ratio of 16.90.

Colgate-Palmolive (NYSE:CLGet Free Report) last released its quarterly earnings data on Friday, July 26th. The company reported $0.91 EPS for the quarter, topping analysts’ consensus estimates of $0.87 by $0.04. The firm had revenue of $5.06 billion for the quarter, compared to the consensus estimate of $5 billion. Colgate-Palmolive had a net margin of 14.21% and a return on equity of 470.19%. The firm’s revenue was up 4.9% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.77 earnings per share. On average, research analysts expect that Colgate-Palmolive will post 3.57 earnings per share for the current fiscal year.

Colgate-Palmolive Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, August 15th. Shareholders of record on Friday, July 19th will be paid a dividend of $0.50 per share. The ex-dividend date of this dividend is Friday, July 19th. This represents a $2.00 annualized dividend and a yield of 1.98%. Colgate-Palmolive’s dividend payout ratio is currently 63.29%.

Insiders Place Their Bets

In other Colgate-Palmolive news, insider Sally Massey sold 12,226 shares of the business’s stock in a transaction that occurred on Thursday, May 9th. The shares were sold at an average price of $94.06, for a total transaction of $1,149,977.56. Following the completion of the sale, the insider now directly owns 13,924 shares in the company, valued at $1,309,691.44. The transaction was disclosed in a legal filing with the SEC, which is available through this link. In other Colgate-Palmolive news, insider Sally Massey sold 12,226 shares of the business’s stock in a transaction that occurred on Thursday, May 9th. The shares were sold at an average price of $94.06, for a total transaction of $1,149,977.56. Following the completion of the sale, the insider now directly owns 13,924 shares in the company, valued at $1,309,691.44. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, insider John W. Kooyman sold 3,497 shares of the company’s stock in a transaction on Tuesday, May 7th. The shares were sold at an average price of $93.47, for a total transaction of $326,864.59. Following the completion of the transaction, the insider now owns 3,181 shares of the company’s stock, valued at $297,328.07. The disclosure for this sale can be found here. 0.34% of the stock is owned by insiders.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in the company. Norges Bank acquired a new stake in Colgate-Palmolive in the fourth quarter valued at $731,843,000. Price T Rowe Associates Inc. MD raised its holdings in shares of Colgate-Palmolive by 27.8% during the first quarter. Price T Rowe Associates Inc. MD now owns 41,067,130 shares of the company’s stock worth $3,698,096,000 after purchasing an additional 8,933,912 shares during the period. Swedbank AB acquired a new stake in shares of Colgate-Palmolive during the first quarter worth $286,370,000. Magellan Asset Management Ltd raised its holdings in shares of Colgate-Palmolive by 4,162.6% during the fourth quarter. Magellan Asset Management Ltd now owns 2,016,290 shares of the company’s stock worth $160,718,000 after purchasing an additional 1,968,988 shares during the period. Finally, Confluence Investment Management LLC acquired a new stake in shares of Colgate-Palmolive during the first quarter worth $130,622,000. 80.41% of the stock is currently owned by hedge funds and other institutional investors.

About Colgate-Palmolive

(Get Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Further Reading

Analyst Recommendations for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.